Valued at a market cap of $16.5 billion, Alexandria Real Estate Equities, Inc. (ARE) is a life science REIT with a particular focus on collaborative life science, agtech and technology campuses. The Pasadena, California-based company is a pioneer of the life science real estate niche and owns, operates, and develops collaborative mega campuses in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, and New York City to name a few.
Shares of this REIT have significantly lagged behind the broader market over the past 52 weeks. ARE has declined 21.3% over this time frame, while the broader S&P 500 Index ($SPX) has gained 20.7%. Moreover, on a YTD basis, the stock is down 2%, compared to SPX’s 2.2% rise.
